Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Which experimental data is included in claims of antibody drug patents?

Managing IP Correspondent
September 18, 2019

Masato Iida of Shiga examines examples of patent claims related to antibody drugs, assessing which data is included in claims

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Topics

Features
managing-ip.png
Managing IP Correspondent
Contact
more from across site and ros bottom lb

More from across our site

Loudspeaker.jpg
Weekly take: Humans of Bombay’s copyright claim could be a tall story
Online storytelling platform Humans of Bombay isn’t wrong for trying to protect its copyright, but it could have handled its dispute better
Sukanya Sarkar, September 26, 2023
Managing IP APAC Awards
Managing IP Awards 2024: in-house submissions invited
We have started accepting submissions from in-house counsel and teams for the 19th annual Managing IP Awards programme
Chris Adams, September 26, 2023
Access to drug.jpg
Counsel fear India's patent reform could spark drug access inequity
Patient groups and generics makers may have to bear the brunt of India’s latest attempt at patent reform
Sukanya Sarkar, September 25, 2023
Tsuyoshi Sueyoshi.JPG
Five minutes with … Tsuyoshi Sueyoshi, Yuasa and Hara
Each week Managing IP speaks to a different IP lawyer about their life and career
Max Walters, September 25, 2023
Top view design on blue background of Hand shaking which print screen on wooden cube block which connection with human icon for business deal and agreement concept.
Exclusive: Rouse hires M&A expert as new COO
Paolo Tavolato, who will share the role, said private equity support would help the IP consultancy achieve its ambitious M&A plans
Rory O’Neill, September 25, 2023
India.jpg
India’s largest firm poaches Anand & Anand partner to kickstart IP practice
Cyril Amarchand Mangaldas has hired former Anand & Anand partner Swati Sharma and hopes to compete with specialist IP firms
Sukanya Sarkar, September 22, 2023
Documents locked with padlock and chains.
UPC denies member of the public access to pleadings
Rapporteur-Judge András Kupecz ruled that education and training weren’t legitimate reasons for a member of the public to access documents
Rory O’Neill, September 22, 2023
Employer with magnifying glass exploring application papers
Counsel: Fed Circuit design patent case decreases prior art burden
Searches for comparison prior art will be a little easier, but practitioners will have to put more thought into claim construction and design patent titles
Rani Mehta, September 22, 2023
Helsinki, Finland
UPC refuses preliminary injunction over earlier opt-out
The Helsinki local division rejected AIM Sport’s request for a preliminary injunction in a dispute with rival Supponor
Rory O’Neill, September 22, 2023
Court of Appeals Federal Circuit Lafayette Park Washington DC
This week on MIP: UPC issues first injunction, Newman ban
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Rory O’Neill, September 22, 2023